DOSSIER · 13F Holders · Q2 2026
NASUS PHARMA LTD
9 institutions still hold NASUS PHARMA LTD as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP M7071P109·9 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
9 institutions reported NASUS PHARMA LTD in Q2 2026. BALYASNY ASSET MANAGEMENT L.P. leads at 42.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.